advanced search

Bryllan

Bryllan is a CDMO supporting clinical and commercial supply of complex drug and device products with a focus on aseptic powder and liquid filling capacity in a range of sterile containers for potent and cytotoxic compounds, hormones, antibodies, complex biologics, live viruses and vaccines.


Visit Website

Phone / Contact

T: +1 248 442 2960
E: [email protected]

Connect

Bryllan is a CDMO supporting clinical and commercial supply of complex drug and device products. With a high containment state-of the-art facility that offers considerable flexibility in capabilities, Bryllan can safely fill potent and cytotoxic compounds, hormones, antibodies, complex biologics, live viruses and vaccines in a wide range of sterile containers.

Bryllan’s focus on aseptic powder and liquid filling capacity in multi-chambered components including syringes, IV bags and cartridges offers drug developers options to develop ready-to-use and ready-to-mix product formats.

The company was founded in 2010 and is privately owned.

Authors and Contacts

Dr Doug Bryans
Founder, President and Chief Executive Officer

Article

INTERVIEW
Dr Doug Bryans
INTERVIEW: DOUG BRYANS, BRYLLAN & JOHN MERHIGE, CREDENCE
Douglas Bryans and John Merhige discuss the changing needs of drug developers around novel dual-chamber and ready-to-use drug delivery devices, capacity and the delivery of complete solutions from CDMOs and device developers, anchored around the recently announced partnership between Credence MedSystems and Bryllan to provide these critical services.
Top